Introduction: emerging therapies derived from the molecular pathogenesis of secondary hyperparathyroidism in ESRD patients.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/B2E2C950.svg?ark=w1%2F20260515%2FB2E2C950)](https://nobleid.org/work/w1/20260515/B2E2C950)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors